Polycystic Ovary Syndrome is a hormonal and metabolic condition affecting roughly 1 in 10 women of reproductive age. It can cause irregular cycles, acne, excess hair growth, hair thinning, weight changes, fatigue, mood changes, and fertility challenges, though symptoms vary widely from person to person.

Alaia is a digital health companion for women with PCOS. It helps you track symptoms, understand patterns, prepare for doctor appointments, and manage your condition with evidence-based tools. It is not a generic period tracker. It is built specifically for the complexity and variability of PCOS.

How is Alaia different from other PCOS apps?

Most health apps assume regular cycles and focus on fertility. Alaia starts from symptoms, supports four different cycle states including absent periods, and generates specialist-specific appointment prep reports. It also includes advocacy tools for women who are still seeking a diagnosis or have been dismissed by their doctor.

Do I need to track my cycle to use it?

No. Many women with PCOS have highly irregular or absent cycles. Alaia works just as well if you focus on symptoms, mood, energy, or medication tracking instead. Your cycle is one input, not the centre of the app.

Yes. Your data is stored securely in the EU, encrypted at rest and in transit, and belongs only to you. Alaia complies with GDPR, including health data protections under Article 9. You can export or delete your data at any time. We never sell your data.

Is Alaia a medical device?

Alaia is designed as a Class I Software as a Medical Device under EU MDR 2017/745. It is a tracking and information tool, not a diagnostic or treatment tool. We are pursuing reimbursement through public health insurance pathways in Belgium, France, and Germany.

Can I share my data with my doctor?

Yes. Alaia helps you create a clear, specialist-specific visit report you can download, email, or bring to your appointment, making it easier to discuss what has been happening and what matters most.

When can I try Alaia?

Alaia is currently in development with beta launch coming soon. Join the waitlist to be the first to get access.

De PCOS-darmverbinding: ontsteking, insulineresistentie en je microbioom

Laure Santolini

Medeoprichter, Alaia

Gepubliceerd op: April 14, 2026
Leestijd: 9 min lezen

In afwachting van beoordeling door de wetenschappelijke raad

Het verband tussen darmgezondheid en PCOS is een van de meest actieve onderzoeksgebieden op dit moment. Deze post behandelt wat we weten over het microbioom, ontsteking, insulineresistentie en hoe dagelijkse keuzes het plaatje kunnen veranderen.

Op de hoogte blijven

Wees de eerste om het volledige artikel te lezen

Schrijf je in op de Alaia-wachtlijst en we laten je weten wanneer deze post wordt gepubliceerd.

Schrijf je in op de wachtlijst →

Referenties

Tremellen K, Pearce K. Dysbiosis of gut microbiota (DOGMA) - a novel theory for the development of Polycystic Ovarian Syndrome. Medical Hypotheses, 2012.
Lindheim L, et al. Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS). PLOS ONE, 2017.
Teede HJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility, 2023.